Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination
  • Published Date:

    Apr 01 2012

  • Source:
    Vaccine. 30(23):3376-3382.
  • Language:
    English
Filetype[PDF-138.42 KB]


Details:
  • Alternative Title:
    Vaccine
  • Personal Author:
  • Description:
    Background: Recent data suggest that adults with diabetes are at increased risk of incident hepatitis B infection and may suffer increased morbidity or mortality from chronic hepatitis B infection. In October 2011, the Advisory Committee on Immunization Practices (ACIP) recommended hepatitis B vaccination (HepB) for persons with diabetes aged 19–59 years and stated that persons with diabetes aged 60 years and older should be considered for vaccination. Objective: To determine HepB coverage among persons with diabetes aged ≥19 years prior to implementation of the new ACIP recommendation and to determine predictors for vaccination. Methods: We used the 2009 National Health Interview Survey to determine weighted proportions of self-reported HepB coverage (≥1 and ≥3 doses) among persons with diabetes aged ≥19 years. A multivariable logistic regression analysis was performed to determine factors independently associated with vaccination. Results: Overall, 19.5% (95% CI: 17.4–21.6%) and 16.6% (14.7–18.6%) of persons with diabetes, aged ≥19 years, reported receiving ≥1 and ≥3 doses of HepB, respectively, compared with 30.3% (29.4–31.3%) and 26.5% (25.5–27.4%) among persons without diabetes. While unadjusted HepB coverage was higher among persons without diabetes, diabetes status was not associated with ≥1 or ≥3 dose vaccination. Among persons with diabetes, being a healthcare provider (OR 4.2, 2.5–7.0), ever tested for HIV (OR 2.6, 1.8–3.6), high-risk behaviors (OR 1.8, 1.0–3.4, P-value = 0.053) and having some college education (OR 1.7, 1.2–2.4) were all independently associated with vaccination. Conclusion: HepB coverage among persons with diabetes is low. These data can be used to provide a baseline for measuring future progress toward vaccination of persons with diabetes.
  • Subject:
  • Pubmed ID:
    22472793
  • Pubmed Central ID:
    PMC6215488
  • Document Type:
    Journal Article
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 92.92 KB]
    Personal Author:
    Rey-Cuille, Marie-Anne; Seck, Abdoulaye; Njouom, Richard; Chartier, Loïc; Sow, Housseyn Dembel; Mamadou,; Ka, Amadou Sidy; Njankouo, Mohamadou; Rousset, Dominique; Giles-Vernick, Tamara; Unal, Guillemette; Sire, Jean-Marie; Garin, Benoît; Simon, François; Vray, Muriel;
    Published Date:
    May 30 2012
    Source:
    PLoS One. 2012; 7(5).
    Description:
    HBV vaccine was introduced into the Expanded Programme on Immunization (EPI) in Senegal and Cameroon in 2005. We conducted a cross-sectional study in both countries to assess the HBV immune protection among children. All consecutive children under 4 ...
    File Type:
    Filetype[PDF - 92.92 KB]
  2. Filetype[PDF - 471.29 KB]
    Personal Author:
    Groom, Holly C.; Irving, Stephanie A.; Koppolu, Padma; Smith, Ning; Vazquez-Benitez, Gabriela; Kharbanda, Elyse O.; Daley, Matthew F.; Donahue, James G.; Getahun, Darios; Jackson, Lisa A.; Kawai, Alison Tse; Klein, Nicola P.; McCarthy, Natalie L.; Nordin, James D.; Sukumaran, Lakshmi; Naleway, Allison L.;
    Published Date:
    September 05 2018
    Source:
    Vaccine. 36(41):6111-6116
    Description:
    Introduction:Hepatitis B virus (HBV) infection acquired during pregnancy can pose a risk to the infant at birth that can lead to significant and lifelong morbidity. Hepatitis B vaccine (HepB) is recommended for anyone at increased risk for contractin...
    File Type:
    Filetype[PDF - 471.29 KB]
  3. Filetype[PDF - 624.00 KB]
    Personal Author:
    King, Hope; Xing, Jian; Dean, Hazel D.; Holtzman, Deborah;
    Published Date:
    Apr 15 2020
    Source:
    Clin Infect Dis. 70(9):1907-1915
    Description:
    Background.Hepatitis B virus (HBV) infection can be prevented through vaccination. However, previous data show that only about 24%–45% of US adults at high risk of HBV infection are protected. Our aims were to assess prevalence and trends in protec...
    File Type:
    Filetype[PDF - 624.00 KB]
  4. Filetype[PDF - 500.46 KB]
    Personal Author:
    Tohme, Rania A.; Andre-Alboth, Jocelyne; Tejada-Strop, Alexandra; Shi, Ran; Boncy, Jacques; François, Jeannot; Domercant, Jean Wysler; Griswold, Mark; Hyppolite, Erlantz; Adrien, Paul; Kamili, Saleem;
    Published Date:
    Jan 28 2016
    Source:
    J Clin Virol. 76:66-71.
    Description:
    BackgroundHepatitis B vaccine administered shortly after birth is highly effective in preventing mother to child transmission (MTCT) of infection. While hepatitis B vaccine was introduced in Haiti as part of a combined pentavalent vaccine in 2012, a ...
    File Type:
    Filetype[PDF - 500.46 KB]
  5. Filetype[PDF - 189.56 KB]
    Personal Author:
    Bender, Thomas John; Sharapov, Umid; Utah, Okey; Xing, Jian; Hu, Dale; Rybczynska, Jolanta; Drobeniuc, Jan; Kamili, Saleem; Spradling, Philip R.; Moorman, Anne C.;
    Published Date:
    Dec 23 2013
    Source:
    Vaccine. 32(7):852-856.
    Description:
    BackgroundFailure to adhere to infection control guidelines, especially during assisted monitoring of blood glucose, has caused multiple hepatitis B outbreaks in assisted living facilities (ALFs). In conjunction with the response to such an outbreak ...
    File Type:
    Filetype[PDF - 189.56 KB]